Totowa, NJ – July 17, 2014 – BiologicTx® was selected as the specialty pharmacy for the observational treatment registry study to evaluate the long-term treatment effects of immune globulin intravenous (IGIV) maintenance therapy on donor specific antibodies (DSA) in renal transplant recipients. Study sponsors are Databean of Mount Vernon, NY and eMax Health of White Plains, NY.
Recent News
Featured
